LUXTURNA®
Indications

Luxturna is indicated for the treatment of adult and pediatric patients with inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations and who have sufficient viable retinal cells as determined by the treating physician(s).

LUXTURNA®

Package Insert

HSA - Approved RMP – Patient Card

HSA - Approved RMP – Patient Leaflet

HSA Approved RMP – Pharmacy Manual HSA Approved RMP – Surgical Manual

Rate this content: 
0
No votes yet
SG2207216672, SG2203089387
×

Medical Information Request

×

Ask Speakers